This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Ucb Biosciences, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Eric Scharin: Innovator in Aqueous Solutions
Introduction
Eric Scharin is a notable inventor based in Emeryville, CA (US). He has made significant contributions to the field of biochemistry, particularly in the development of aqueous solutions containing purines and pyrimidines. His work has implications for treating mitochondrial depletion syndromes, showcasing the intersection of chemistry and medicine.
Latest Patents
Eric Scharin holds 1 patent for his invention titled "Aqueous solutions containing purines and pyrimidines and uses thereof." This patent describes compositions that include a first heteroaryl compound and a second heteroaryl compound dissolved in an aqueous liquid. The methods outlined in the patent involve orally administering this aqueous liquid to patients diagnosed with mitochondrial depletion syndrome. Additionally, the patent includes kits that comprise the necessary compounds and instructions for their preparation and administration.
Career Highlights
Eric Scharin is currently associated with UCB Biosciences, Inc., where he continues to innovate in the field of biochemistry. His work is characterized by a commitment to developing solutions that address critical health issues. His research has the potential to improve patient outcomes through novel therapeutic approaches.
Collaborations
Eric collaborates with Paul Glidden, a fellow professional in the field. Their partnership exemplifies the collaborative spirit that drives innovation in scientific research.
Conclusion
Eric Scharin's contributions to the field of biochemistry, particularly through his patented aqueous solutions, highlight his role as an innovator dedicated to advancing medical treatments. His work continues to inspire and pave the way for future developments in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile